Breaking News Instant updates and real-time market news.

TROV

Trovagene

$0.81

-0.0068 (-0.83%)

17:22
06/22/18
06/22
17:22
06/22/18
17:22

Trovagene CEO William Welch resigns, Dr. Thomas Adams named interim CEO

Trovagene announced that William Welch has resigned from his positions as CEO and Director for personal reasons, effective immediately. While the company conducts a search for a new CEO, the company's Chairman, Dr. Thomas Adams, has been appointed interim CEO. Dr. Adams has been the company's Chairman of the Board since April 2009.

TROV Trovagene
$0.81

-0.0068 (-0.83%)

12/21/17
HCWC
12/21/17
INITIATION
Target $1
HCWC
Buy
Trovagene initiated with a Buy at H.C. Wainwright
H.C. Wainwright analyst Raghuram Selvaraju started Trovagene with a Buy rating and $1 price target. The analyst believes the company's PCM-075 is differentiated from other ATP-competitive PLK1 inhibitors.
06/15/18
MAXM
06/15/18
UPGRADE
MAXM
Buy
Trovagene upgraded to Buy from Hold at Maxim
06/18/18
MAXM
06/18/18
UPGRADE
Target $3
MAXM
Buy
Trovagene upgraded to Buy at Maxim on positive PCM-075 news
As reported earlier Maxim analyst Jason McCarthy upgraded Trovagene to Buy from Hold with a price target of $3, citing the positive news from the company's lead drug candidate PCM-075 as well as its completion of a capital raise. The analyst notes that Trovagene's balance sheet now gives it a run rate into the second half of 2019 while the PCM-075 studies progress toward their next set of catalysts. Given the suspension of the financing overhang, McCarthy says the company's potential justifies a more constructive stance.
06/18/18
06/18/18
UPGRADE

On The Fly: Top five analyst upgrades
Catch up on today's top five analyst upgrades with this list compiled by The Fly: 1. Francesca's (FRAN) upgraded to Buy from Neutral at B. Riley FBR with analyst Susan Anderson saying she has increased confidence in the company's turnaround following meetings with management. 2. Chevron (CVX) upgraded to Outperform from Market Perform at Raymond James with analyst Pavel Molchanov saying Chevron offers relatively more leverage than most peers to higher oil prices, which should reach cyclical highs over the next 6 to 12 months, while low WTI exposure maximizes earnings and free cash flow generation. 3. Trovagene (TROV) upgraded to Buy from Hold at Maxim with analyst Jason McCarthy citing the positive news from the company's lead drug candidate PCM-075 as well as its completion of a capital raise. 4. RBS (RBS) upgraded to Buy from Hold at Investec. 5. Teva (TEVA) upgraded to Market Perform from Underperform at Wells Fargo with analyst David Maris citing a "positive meeting" with Teva's CEO Kundefinedre Schultz and CFO Mike McClellan in Israel. This list is just a portion of The Fly's full analyst coverage. To see The Fly's full Street Research coverage, click here.

TODAY'S FREE FLY STORIES

IT

Gartner

$148.85

3.89 (2.68%)

08:16
10/15/18
10/15
08:16
10/15/18
08:16
Conference/Events
Gartner to hold a symposium »

Gartner Symposium: ITxpo…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 07

    Nov

  • 08

    Nov

QQQ

Invesco QQQ Trust

$174.28

4.59 (2.70%)

08:16
10/15/18
10/15
08:16
10/15/18
08:16
Technical Analysis
Invesco QQQ Trust: Pivot points »

The following are the…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

IPG

Interpublic Group

$21.41

-0.19 (-0.88%)

08:16
10/15/18
10/15
08:16
10/15/18
08:16
Initiation
Interpublic Group initiated  »

Interpublic Group resumed…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 19

    Oct

$COMP

Nasdaq Composite

$0.00

(0.00%)

08:16
10/15/18
10/15
08:16
10/15/18
08:16
Technical Analysis
Nasdaq Composite: Pivot points »

The following are the…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

RNSDF

Renault

$0.00

(0.00%)

08:16
10/15/18
10/15
08:16
10/15/18
08:16
Downgrade
Renault rating change  »

Renault downgraded to…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

SRPT

Sarepta

$130.79

8.61 (7.05%)

08:16
10/15/18
10/15
08:16
10/15/18
08:16
Hot Stocks
Sarepta signs license agreement with Lysogene for LYS-SAF302 »

Sarepta announced it has…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

NDX

Nasdaq 100 Index

$0.00

(0.00%)

08:16
10/15/18
10/15
08:16
10/15/18
08:16
Technical Analysis
Nasdaq 100 Index: Pivot points »

The following are the…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

DDAIF

Daimler AG

$0.00

(0.00%)

08:16
10/15/18
10/15
08:16
10/15/18
08:16
Downgrade
Daimler AG rating change  »

Daimler AG downgraded to…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

PARR

Par Pacific

$18.80

-0.08 (-0.42%)

08:15
10/15/18
10/15
08:15
10/15/18
08:15
Conference/Events
Argus to hold a summit »

Fuel Oil Summit will be…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

PEG

PSEG

$53.70

0.1 (0.19%)

, RNR

RenaissanceRe

$131.69

-1.45 (-1.09%)

08:15
10/15/18
10/15
08:15
10/15/18
08:15
Conference/Events
Deutsche Bank to hold a conference »

ESG Investing Conference…

PEG

PSEG

$53.70

0.1 (0.19%)

RNR

RenaissanceRe

$131.69

-1.45 (-1.09%)

DB

Deutsche Bank

$10.84

(0.00%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 15

    Oct

  • 11

    Nov

  • 14

    Nov

08:15
10/15/18
10/15
08:15
10/15/18
08:15
General news
U.S. retail sales preview: »

U.S. retail sales…

08:15
10/15/18
10/15
08:15
10/15/18
08:15
General news
Empire State Mfg Survey General Business Conditions Index to be reported at 08:30 »

October Empire State Mfg…

08:15
10/15/18
10/15
08:15
10/15/18
08:15
General news
Retail Sales less autos to be reported at 08:30 »

September Retail Sales…

08:15
10/15/18
10/15
08:15
10/15/18
08:15
General news
Retail Sales to be reported at 08:30 »

September Retail Sales…

ADBE

Adobe

$248.89

10.24 (4.29%)

08:14
10/15/18
10/15
08:14
10/15/18
08:14
Conference/Events
Adobe to hold a conference »

Adobe MAX is being held…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 15

    Oct

AIMT

Aimmune

$26.40

1.23 (4.89%)

, REGN

Regeneron

$384.20

12.47 (3.35%)

08:12
10/15/18
10/15
08:12
10/15/18
08:12
Hot Stocks
Aimmune Therapeutics announces initiation of Phase 2 study of AR101 »

Aimmune Therapeutics…

AIMT

Aimmune

$26.40

1.23 (4.89%)

REGN

Regeneron

$384.20

12.47 (3.35%)

SNY

Sanofi

$42.89

-0.83 (-1.90%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 19

    Oct

  • 19

    Oct

  • 20

    Oct

  • 23

    Oct

  • 28

    Oct

  • 29

    Oct

  • 06

    Nov

  • 28

    Jan

  • 22

    Mar

  • 28

    Apr

  • 13

    May

SVRA

Savara

$9.94

-0.08 (-0.80%)

08:11
10/15/18
10/15
08:11
10/15/18
08:11
Hot Stocks
Savara completes enrollment of IMPALA Phase 3 study »

Savara announced…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 16

    Oct

KRYS

Krystal Biotech

$15.49

0.58 (3.89%)

08:10
10/15/18
10/15
08:10
10/15/18
08:10
Conference/Events
Krystal Biotech to hold a conference call »

Management holds a…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

IMAX

Imax

$23.04

0.13 (0.57%)

08:10
10/15/18
10/15
08:10
10/15/18
08:10
Hot Stocks
Imax names Megan Colligan President, IMAX Entertainment and Executive VP, IMAX »

IMAX appointed Megan…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 25

    Oct

  • 14

    Nov

XYF

X Financial

$9.55

0.05 (0.53%)

08:10
10/15/18
10/15
08:10
10/15/18
08:10
Initiation
X Financial initiated  »

X Financial initiated…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

LEN

Lennar

$43.15

-0.16 (-0.37%)

08:09
10/15/18
10/15
08:09
10/15/18
08:09
Recommendations
Lennar analyst commentary  »

Lennar price target…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

MANT

ManTech

$56.51

0.74 (1.33%)

08:09
10/15/18
10/15
08:09
10/15/18
08:09
Hot Stocks
ManTech awarded $45M contract for NSWC »

ManTech announced a $45M…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 01

    Nov

TXT

Textron

$65.07

-0.015 (-0.02%)

, BRK.A

Berkshire Hathaway

$310,740.00

2727.91 (0.89%)

08:09
10/15/18
10/15
08:09
10/15/18
08:09
Hot Stocks
Textron Aviation, NetJets announce agreements for option to expand fleet »

Textron Aviation, a…

TXT

Textron

$65.07

-0.015 (-0.02%)

BRK.A

Berkshire Hathaway

$310,740.00

2727.91 (0.89%)

BRK.B

Berkshire Hathaway

$206.72

1.41 (0.69%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 18

    Oct

KTOS

Kratos Defense

$12.99

-0.04 (-0.31%)

, HRS

Harris

$154.88

0.61 (0.40%)

08:07
10/15/18
10/15
08:07
10/15/18
08:07
Hot Stocks
Kratos licenses CDL waveforms for use in Harris' nanoSVDL radios »

Kratos Defense &…

KTOS

Kratos Defense

$12.99

-0.04 (-0.31%)

HRS

Harris

$154.88

0.61 (0.40%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 15

    Oct

  • 16

    Oct

CRON

Cronos Group

$9.86

0.82 (9.07%)

08:07
10/15/18
10/15
08:07
10/15/18
08:07
Hot Stocks
Cronos Group partners with Technion R&D Foundation for skin-care treatments »

Cronos Group has entered…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

Get Full Fly Access

Breaking market intelligence sent straight to you
Our team of experts analyze every news story and filter out the noise to deliver real-time market moving news.
Up-to-date information on important industry events
Get real-time updates on events that are moving the market—from conferences and calls to syndicate announcements.
News focused on the companies in your portfolio
Create up to 12 portfolios with 150 stocks each, and see how active they are in market news.